153 related articles for article (PubMed ID: 32362670)
1. Compounded Topical Amitriptyline for Neuropathic Pain: In Vitro Release from Compounding Bases and Potential Correlation with Clinical Efficacy.
Shakshuki A; Yeung P; Agu RU
Can J Hosp Pharm; 2020; 73(2):133-140. PubMed ID: 32362670
[TBL] [Abstract][Full Text] [Related]
2. Compounded Topical Gabapentin for Neuropathic Pain: Does Choice of Base Affect Efficacy?
Shakshuki A; Agu RU
Int J Pharm Compd; 2019; 23(6):496-503. PubMed ID: 31751946
[TBL] [Abstract][Full Text] [Related]
3. Stability Assessment of Topical Amitriptyline Extemporaneously Compounded with Lipoderm Base, PLO Gel Mediflo 30, and Emollient Cream.
Shakshuki A; Agu RU
Int J Pharm Compd; 2019; 23(1):82-87. PubMed ID: 30668540
[TBL] [Abstract][Full Text] [Related]
4. In Vitro Permeability, Irritability, and Release Evaluation of Commonly Used Topical Diclofenac Gel Preparations (1%, 5%, and 10%).
Kohan HG; Baker DM; Sani S; Bielecki-Wilken KA; Ramirez A
Int J Pharm Compd; 2021; 25(2):146-155. PubMed ID: 33798114
[TBL] [Abstract][Full Text] [Related]
5. Skin Permeation and Antinociception of Compounded Topical Cyclobenzaprine Hydrochloride Formulations.
Bryson E; Hartman R; Arnold J; Gorman G; Sweitzer S; Asbill S
Int J Pharm Compd; 2015; 19(2):161-6. PubMed ID: 26685496
[TBL] [Abstract][Full Text] [Related]
6. Compounded gabapentin for neuropathic pain: Stability and beyond-use date (BUD) in some commonly used bases.
Shakshuki A; Yeung P; Agu RU
J Am Pharm Assoc (2003); 2019; 59(4):514-520. PubMed ID: 30979575
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the percutaneous absorption of promethazine hydrochloride, in vitro, using the human ex vivo skin model.
Bassani AS; Banov D; Lehman PA
Int J Pharm Compd; 2008; 12(3):270-3. PubMed ID: 23969717
[TBL] [Abstract][Full Text] [Related]
8. Impact of the chemical and physical stability of ketoprofen compounded in various pharmaceutical bases on its topical and transdermal delivery.
Nornoo AO; Wulz J; Yoon H; Nan Y; Lese M
Pharm Dev Technol; 2016 Mar; 21(2):204-13. PubMed ID: 25431959
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the Percutaneous Absorption of Ketamine HCl, Gabapentin, Clonidine HCl, and Baclofen, in Compounded Transdermal Pain Formulations, Using the Franz Finite Dose Model.
Bassani AS; Banov D
Pain Med; 2016 Feb; 17(2):230-8. PubMed ID: 26352507
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the Percutaneous Absorption of Ketoprofen Using the Franz Skin Finite Dose Model.
Bassani AS; Banov D; Phan H
Postgrad Med; 2016; 128(2):262-7. PubMed ID: 26788899
[TBL] [Abstract][Full Text] [Related]
11. Skin permeation and antinociception of topical gabapentin formulations.
Bryson E; Asbill S; Sweitzer S
Int J Pharm Compd; 2014; 18(6):504-11. PubMed ID: 25906628
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Transdermal Drug Permeation as Modulated by Lipoderm and Pluronic Lecithin Organogel.
Zhang Q; Song Y; Page SW; Garg S
J Pharm Sci; 2018 Feb; 107(2):587-594. PubMed ID: 28935590
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of in vitro transdermal permeation, mass spectrometric imaging, and in vivo analgesic effects of pregabalin using a pluronic lecithin organogel formulation in mice.
Nagao M; Tajima M; Sugiyama E; Shinouchi R; Shibata K; Yoshikawa M; Yamamoto T; Sato VH; Nobe K; Sato H
Pharmacol Res Perspect; 2022 Apr; 10(2):e00919. PubMed ID: 35306752
[TBL] [Abstract][Full Text] [Related]
14. Transdermal delivery of nicardipine: an approach to in vitro permeation enhancement.
Aboofazeli R; Zia H; Needham TE
Drug Deliv; 2002; 9(4):239-47. PubMed ID: 12511202
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Compounded Transdermal Analgesic Formulations Using the Franz Finite Dose Model.
Baneshi M; Tyagi D; Panneerselvam E; MacKenzie G; Coleman J; Zhang SX
Int J Pharm Compd; 2023; 27(5):424-430. PubMed ID: 37816184
[TBL] [Abstract][Full Text] [Related]
16. Mycophenolic Acid for Topical Immunosuppression in Vascularized Composite Allotransplantation: Optimizing Formulation and Preliminary Evaluation of Bioavailability and Pharmacokinetics.
Feturi FG; Weinstock M; Zhao W; Zhang W; Schnider JT; Erbas VE; Oksuz S; Plock JA; Rohan L; Spiess AM; Ferreira LM; Solari MG; Venkataramanan R; Gorantla VS
Front Surg; 2018; 5():20. PubMed ID: 29868602
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a compounding phospholipid base for the percutaneous absorption of high molecular weight drugs using the Franz finite dose model.
Banov D; Song G; Carvalho M; Bassani AS; Valdez BC
Skin Res Technol; 2024 Feb; 30(2):e13610. PubMed ID: 38352988
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the percutaneous absorption of chlorpromazine from PLO gels across porcine ear and human abdominal skin.
Alsaab H; Alzhrani RM; Boddu SH
Drug Dev Ind Pharm; 2016 Aug; 42(8):1258-66. PubMed ID: 26599694
[TBL] [Abstract][Full Text] [Related]
19. Development and Evaluation of Topical Gabapentin Formulations.
Martin CJ; Alcock N; Hiom S; Birchall JC
Pharmaceutics; 2017 Aug; 9(3):. PubMed ID: 28867811
[TBL] [Abstract][Full Text] [Related]
20. Optimization and evaluation of pluronic lecithin organogels as a transdermal delivery vehicle for sinomenine.
Ba W; Li Z; Wang L; Wang D; Liao W; Fan W; Wu Y; Liao F; Yu J
Pharm Dev Technol; 2016 Aug; 21(5):535-45. PubMed ID: 25757643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
